[go: up one dir, main page]

HK1155942A1 - Transdermal estradiol device and delivery - Google Patents

Transdermal estradiol device and delivery Download PDF

Info

Publication number
HK1155942A1
HK1155942A1 HK11109973.9A HK11109973A HK1155942A1 HK 1155942 A1 HK1155942 A1 HK 1155942A1 HK 11109973 A HK11109973 A HK 11109973A HK 1155942 A1 HK1155942 A1 HK 1155942A1
Authority
HK
Hong Kong
Prior art keywords
estradiol
drug delivery
weight
delivery system
polymer matrix
Prior art date
Application number
HK11109973.9A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1155942B (en
Inventor
Juan Mantelle
Original Assignee
Noven Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41119408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1155942(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharmaceuticals, Inc. filed Critical Noven Pharmaceuticals, Inc.
Publication of HK1155942A1 publication Critical patent/HK1155942A1/en
Publication of HK1155942B publication Critical patent/HK1155942B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11109973.9A 2008-07-10 2009-07-09 Transdermal estradiol device and delivery HK1155942B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/216,811 2008-07-10
US12/216,811 US8231906B2 (en) 2008-07-10 2008-07-10 Transdermal estrogen device and delivery
PCT/US2009/050069 WO2010006143A2 (en) 2008-07-10 2009-07-09 Transdermal estrogen device and delivery

Publications (2)

Publication Number Publication Date
HK1155942A1 true HK1155942A1 (en) 2012-06-01
HK1155942B HK1155942B (en) 2015-11-20

Family

ID=

Also Published As

Publication number Publication date
JP2011527697A (ja) 2011-11-04
EP3173078A1 (en) 2017-05-31
CA2729950C (en) 2016-11-08
US20100008991A1 (en) 2010-01-14
US9730900B2 (en) 2017-08-15
DK2310001T3 (da) 2015-09-14
WO2010006143A3 (en) 2011-04-07
CA2729950A1 (en) 2010-01-14
US20150272905A1 (en) 2015-10-01
US9724310B2 (en) 2017-08-08
RU2014125322A (ru) 2015-12-27
CL2009001556A1 (es) 2010-04-30
PT2310001E (pt) 2015-10-05
JP2015017118A (ja) 2015-01-29
US20130156815A1 (en) 2013-06-20
JP2017039781A (ja) 2017-02-23
RU2526186C2 (ru) 2014-08-20
AR072492A1 (es) 2010-09-01
UY31975A (es) 2010-02-26
US20140200530A1 (en) 2014-07-17
MX2011000332A (es) 2011-04-05
RU2011101477A (ru) 2012-08-20
WO2010006143A2 (en) 2010-01-14
TWI511733B (zh) 2015-12-11
KR20110039331A (ko) 2011-04-15
TW201004630A (en) 2010-02-01
ES2548457T3 (es) 2015-10-16
JP6118774B2 (ja) 2017-04-19
EP2310001B1 (en) 2015-07-01
JP5676440B2 (ja) 2015-02-25
US9833419B2 (en) 2017-12-05
US20160015655A1 (en) 2016-01-21
US8231906B2 (en) 2012-07-31
EP2310001A2 (en) 2011-04-20

Similar Documents

Publication Publication Date Title
US9833419B2 (en) Transdermal estrogen device and delivery
US9320742B2 (en) Transdermal testosterone device and delivery
US10987316B2 (en) Compositions and methods for transdermal delivery of tertiary amine drugs
US8784877B2 (en) Transdermal levonorgestrel device and delivery
CA2896055C (en) Compositions and methods for transdermal delivery of amphetamine and clonidine
US10231977B2 (en) Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
US20140276479A1 (en) Transdermal drug delivery system with overlay
US20170112781A1 (en) Transdermal drug delivery systems with polyisobutylene face adhesive
WO2017004507A1 (en) Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
HK1155942B (en) Transdermal estradiol device and delivery
US20180036319A1 (en) Transdermal drug delivery systems for norethindrone acetate

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190709